538965 logo

Concord Drugs Limited Stock Price

BSE:538965 Community·₹1.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

538965 Share Price Performance

₹0
-30.13 (-100.00%)
₹0
-30.13 (-100.00%)
Price ₹0

538965 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet with slight risk.

4 Risks
1 Reward

Concord Drugs Limited Key Details

₹512.4m

Revenue

₹418.5m

Cost of Revenue

₹93.9m

Gross Profit

₹88.2m

Other Expenses

₹5.7m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
May 30, 2026
0.43
18.32%
1.10%
55.6%
View Full Analysis

About 538965

Founded
1995
Employees
250
CEO
Seelam Reddy
WebsiteView website
concorddrugs.in

Concord Drugs Limited engages in the manufacture and sale of pharmaceutical formulations in India. It offers tissue bio-adhesive products; ready-to-fill pellets and multiple unit pellets system; other drugs in the form of tablets, capsules, small volume parenterals, dry powders, syrups and suspension, and dry syrups; and hand sanitizers. The company was incorporated in 1995 and is based in Hyderabad, India.

Recent 538965 News & Updates

Recent updates

No updates